An open-label, 12 months safety and efficacy study of Levodopa- carbidopa intestinal gel in levodopa-responsive subjects with advanced parkinson's disease and severe motor-fluctuations despite optimized treatment with available parkinson's disease medications

ID Number 09-2309

Principal Investigator(s)
Catherine Cho

Department(s) or Division(s)


The purpose of this study is to find out how well an experimental drug gel and delivery system works as treatment of Parkinson's Disease and how safe it is when taken for 12 months.

Contact Information
Joan Bratton, Study Coordinator
(212) 241-0279

Recruiting Patients: No